Novartis’ Foradil Certihaler Approved For Asthma
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approval of asthma treatment follows receipt of two “approvable” letters.
You may also be interested in...
New Foradil Inhaler Falls Prey To Concerns About Single-Entity LABA Products
Novartis Foradil Certihaler (formoterol fumarate inhalation powder) is the first victim of a recommendation by several FDA advisory committees to withdraw the asthma indication for formoterol and salmeterol
New Foradil Inhaler Falls Prey To Concerns About Single-Entity LABA Products
Novartis Foradil Certihaler (formoterol fumarate inhalation powder) is the first victim of a recommendation by several FDA advisory committees to withdraw the asthma indication for formoterol and salmeterol
Sepracor COPD Treatment Approved
Brovana will be first-to-market long-acting bronchodilator developed in an inhalation solution for use with a nebulizer.